Pharmacokinetics of an increased atazanavir dose with and without tenofovir during the third trimester of pregnancy
BACKGROUND: Reduced atazanavir exposure has been demonstrated during pregnancy with standard atazanavir/ritonavir dosing. We studied an increased dose during the third trimester of pregnancy. METHODS: International Maternal Pediatric Adolescent AIDS Clinical Trials Group 1026s is a prospective, nonb...
Saved in:
Main Authors: | Regis Kreitchmann, Brookie M. Best, Jiajia Wang, Alice Stek, Edmund Caparelli, D. Heather Watts, Elizabeth Smith, David E. Shapiro, Steve Rossi, Sandra K. Burchett, Elizabeth Hawkins, Mark Byroads, Tim R. Cressey, Mark Mirochnick |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84876294301&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/52877 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Pharmacokinetics of an increased atazanavir dose with and without tenofovir during the third trimester of pregnancy
by: Regis Kreitchmann, et al.
Published: (2018) -
Raltegravir pharmacokinetics during pregnancy
by: D. Heather Watts, et al.
Published: (2018) -
Raltegravir pharmacokinetics during pregnancy
by: D. Heather Watts, et al.
Published: (2018) -
Efavirenz pharmacokinetics during pregnancy and infant washout
by: Regis Kreitchmann, et al.
Published: (2019) -
Pharmacokinetics of once versus twice daily darunavir in pregnant HIV-infected women
by: Alice Stek, et al.
Published: (2018)